BioAdaptives (BDPT) Financial Statements

24 Followers

BioAdaptives Financial Overview

BioAdaptives's market cap is currently $315.08K. The company's EPS TTM is $-0.1102; its P/E ratio is -0.01; BioAdaptives is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 18.28K	$ 12.67K	$ 28.57K	$ 17.18K	$ 19.78K
Gross Profit	$ 12.50K	$ 4.03K	$ 10.82K	$ 7.13K	$ 10.11K
Operating Income	$ -1.04M	$ -602.00K	$ -229.00K	$ -422.00K	$ -636.00K
EBITDA	$ -1.03M	$ -582.15K	$ -521.00K	$ -544.00K	$ -644.00K
Net Income	$ -1.56M	$ -899.00K	$ -712.00K	$ -896.00K	$ -1.05M
Balance Sheet
Cash & Short-Term Investments	$ 158.44K	$ 137.47K	$ 60.78K	$ 25.45K	$ 83.13K
Total Assets	$ 225.90K	$ 261.88K	$ 104.00K	$ 37.31K	$ 148.59K
Total Debt	$ 384.43K	$ 343.10K	$ 329.18K	$ 392.04K	$ 436.83K
Net Debt	$ 225.98K	$ 205.63K	$ 268.40K	$ 366.63K	$ 353.90K
Total Liabilities	$ 2.36M	$ 1.73M	$ 1.75M	$ 1.49M	$ 1.24M
Stockholders' Equity	$ -2.13M	$ -1.46M	$ -1.65M	$ -1.45M	$ -1.09M
Cash Flow
Free Cash Flow	$ -534.02K	$ -249.52K	$ -223.77K	$ -227.26K	$ -158.65K
Operating Cash Flow	$ -516.02K	$ -249.52K	$ -223.77K	$ -227.26K	$ -158.65K
Investing Cash Flow	$ -18.00K	$ 0.00	$ 0.00	$ 148.00	$ 254.00
Financing Cash Flow	$ 555.00K	$ 326.21K	$ 259.14K	$ 169.73K	$ 237.00K

Currency in USD

BioAdaptives Earnings and Revenue History

Income Statement >

BioAdaptives Debt to Assets

Balance Sheet >

BioAdaptives Cash Flow

Cash Flow >

BioAdaptives Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >